Drug Discovery of Host CLK1 Inhibitors for Influenza Treatment-Reference-Cited by-同舟云学术

Drug Discovery of Host CLK1 Inhibitors for Influenza Treatment

Published:2015-11-02 Issue:11 Volume:20 Page:19735-19747
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Zu Mian,Li Chao,Fang Jian-Song,Lian Wen-Wen,Liu Ai-Lin,Zheng Li-Shu,Du Guan-Hua

Funder

Beijing Natural Science Foundation

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/20/11/19653/pdf

Reference25 articles.

1. The gene structure and replication of influenza virus;Lamb;Ann. Rev. Biochem.,1983

2. Why should influenza be a public health priority?

3. Adamantane-Resistant Influenza A Viruses in the World (1902–2013): Frequency and Distribution of M2 Gene Mutations

4. Clinical Implications of Antiviral Resistance in Influenza

5. N-terminus of the protein kinase CLK1 induces SR protein hyperphosphorylation

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling the influenza virus inhibitory potential: Ligand-based docking, pharmacophore, MM-GBSA, and molecular dynamic simulation of phytochemicals and cyanobacteria metabolites;Intelligent Pharmacy;2024-02

2. Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases;Signal Transduction and Targeted Therapy;2023-04-07

3. Roles of alternative splicing in infectious diseases: from hosts, pathogens to their interactions;Chinese Medical Journal;2023-03-09

4. Discovery of novel 5-methoxybenzothiophene hydrazides as metabolically stable Clk1 inhibitors with high potency and unprecedented Clk1 isoenzyme selectivity;European Journal of Medicinal Chemistry;2023-02

5. An overview of cdc2‐like kinase 1 (Clk1) inhibitors and their therapeutic indications;Medicinal Research Reviews;2022-10-19